Thomas Michael Ricart MD PhD (He/Him)
Child & Adolescent Psychiatry
Physician
Join to view full profile
252 County Road 601Belle Mead, NJ 08502
Phone+1 908-281-1455
Fax+1 908-281-1321
Dr. Ricart is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Icahn School of Medicine at Mount SinaiResidency, Peds/Psych/Child-Adolescent Psych, 2012 - 2017
Rutgers New Jersey Medical SchoolClass of 2012
Certifications & Licensure
NJ State Medical License 2017 - 2027
NY State Medical License 2014 - 2017
American Board of Psychiatry and Neurology Psychiatry- American Board of Psychiatry and Neurology Child & Adolescent Psychiatry
Publications & Presentations
PubMed
- 54 citationsThe role of the kynurenine pathway in suicidality in adolescent major depressive disorderKailyn A.L. Bradley, Julia A.C. Case, Omar Khan, Thomas Ricart, Amira Hanna
Psychiatry Research. 2015-06-30 - 33 citationsVulnerability factors in anxiety: Strain and sex differences in the use of signals associated with non-threat during the acquisition and extinction of active-avoidance...Kevin D. Beck, Xilu Jiao, Thomas M. Ricart, Catherine E. Myers, Thomas R. Minor
Progress in Neuro-Psychopharmacology & Biological Psychiatry. 2011-08-15 - 21 citationsClassical and instrumental conditioning of eyeblink responses in Wistar–Kyoto and Sprague–Dawley ratsThomas M. Ricart, Xilu Jiao, Kevin C.H. Pang, Kevin D. Beck, Richard J. Servatius
Behavioural Brain Research. 2011-01-01
Press Mentions
Hackensack Meridian Health Opens New Child and Adolescent Mental Health Facility, Expanding Critically Needed State-of-the-Art Care for Youths in CrisisJune 9th, 2026
Grant Support
- Laboratory Developed Test (LDT) to Support Clinical Evaluation of a Drug for Painful Diabetic NeuropathyPLUMERIA THERAPEUTICS, INC.2021–2027
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
